Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04171327 versus prednisone and placebo in active rheumatoid arthritis on methotrexate
2010-023782-22Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fosdagrocorat in rheumatoid arthritis (RA) (7 arms), sponsored by Pfizer. Primary endpoints: ACR20 at week 8, P1NP at week 8 and 1 more. Started Jul 2011; status: completed.
02
Drugs
fosdagrocorat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-023782-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023782-22.